News · 26 weeks129-18%
2025-12-282026-06-21
Mix4890d
- Insider19(40%)
- Other15(31%)
- SEC Filings8(17%)
- Earnings3(6%)
- Offering3(6%)
Latest news
25 items- INSIDEROfficer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Commercial Officer Golwas Douglas P covered exercise/tax liability with 1,889 shares, converted options into 100,000 shares, sold $3,677,115 worth of shares (100,000 units at $36.77) as part of a pre-agreed trading plan and returned 100,000 units of Class B Common Stock to the company, increasing direct ownership by 1,319% to 365,864 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERChief Executive Officer Boyle James M covered exercise/tax liability with 2,370 shares, decreasing direct ownership by 7% to 29,369 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERDirector Galanti Richard A was granted 16,392 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERDirector Sweet Thomas W was granted 17,800 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERDirector Bluedorn Todd M was granted 15,732 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECMedline Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Medline Inc. (0002046386) (Filer)
- INSIDERPrincipal Accounting Officer Corcoran Jessi L bought $170,750 worth of shares (5,000 units at $34.15) (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECMedline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement8-K - Medline Inc. (0002046386) (Filer)
- INSIDERLarge owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERDirector Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- PRMedline's Prime Vendor model expands outside the United StatesAgreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement is with Mohawk Medbuy (MMC), one of Canada's largest healthcare procurement organizations, to support warehouse and supply chain logistics for its hospitals in Southwestern Ontario and builds from best practices from similar agreements with hundreds of healthcare providers in the U.S.
- PRMedline Inc. announces closing of upsized secondary offering of Class A common stockNORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei
- PRMedline announces participation in upcoming investor conferencesNORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET. Webcasts of the presentations will be a
- PRMediWound Reports First Quarter 2026 Financial Results and Provides Corporate UpdateEscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut
- INSIDERLarge owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bcp 8 Holdings Mozart Manager L.L.C. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECSEC Form 424B4 filed by Medline Inc.424B4 - Medline Inc. (0002046386) (Filer)
MDLN FAQ
6 questionsWhere does MDLN stock trade?
Medline Inc. (MDLN) is listed on NASDAQ.What sector and industry is MDLN in?
Medline Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Medline Inc. go public?
Medline Inc. (MDLN) completed its IPO in 2025.What are analysts saying about MDLN?
Medline Inc. has had 8 recent analyst actions on file. The most recent action was from Citigroup: Buy on 2026-03-11. Recent price targets range from $3800.00 to $4800.00.What companies are similar to MDLN?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), RMD (ResMed Inc.). Compare MDLN side-by-side with any of them on Quantisnow.How can I track MDLN on Quantisnow?
Quantisnow aggregates Medline Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDLN to receive live email and push alerts on every new disclosure.